Glycosaminoglycan Composition for Selective ECM Deposition
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
There is a need to improve the provision of macromolecular crowding agents for eukaryotic cell culture to enhance extracellular matrix (ECM) deposition.
Innovation Solution
A composition comprising glycosaminoglycans (GAGs) with a molecular weight distribution of 60 to 2000 kDa, featuring two or more peaks, is used in cell culture media to enhance ECM deposition.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If traditional macromolecular crowding agents (Ficoll, carrageenan) are used in cell culture, then extracellular matrix deposition is enhanced, but the deposition is not selective and collagen type I production is not specifically increased
Solution Approach 1:
The patent segments the macromolecular crowding agent into multiple GAG components with distinct molecular weights (60-2000 kDa range with two or more peaks in molecular weight distribution). This segmentation allows different GAG species to selectively interact with specific collagen types, thereby achieving selective ECM deposition while maintaining high overall deposition rates through the combined effect of all components.
Solution Approach 2:
The patent employs a composite macromolecular crowding agent composed of multiple glycosaminoglycan species with different molecular weights and structures. This composite material provides both the excluded volume effect for enhanced overall ECM deposition and specific molecular interactions for selective collagen type III, IV, V, and VI production over collagen type I.
2Productivity
If single molecular weight GAGs are used as macromolecular crowding agents, then the system is simple to characterize, but ECM deposition enhancement is limited compared to polydisperse GAG mixtures
Solution Approach 1:
The patent changes the molecular weight parameter of GAGs from a single value to a distributed range (60-2000 kDa) with two or more peaks in the molecular weight distribution. This parameter change transforms the crowding agent from a simple monodisperse system to a polydisperse mixture that provides enhanced ECM deposition through the combined excluded volume effects of multiple molecular weight species.
3Manufacturing precision
If polydisperse GAG mixtures are used to enhance ECM deposition, then selective collagen production is achieved, but the composition becomes more complex to manufacture and characterize
Solution Approach 1:
The patent segments the GAG mixture into discrete molecular weight ranges with identifiable peaks (60-2000 kDa), which facilitates manufacturing by allowing the use of commercially available GAG fractions with known molecular weight distributions. This segmentation maintains selectivity for collagen types III, IV, V, and VI while simplifying the manufacturing process compared to creating entirely novel polydisperse mixtures.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The composition significantly enhances specific ECM deposition by selectively increasing the production of collagen types III, IV, V, and VI over collagen I, outperforming traditional agents like Ficoll and carrageenan in certain aspects.
Implementation Method 1
Alongside MMC, the term excluded volume effect (EVE) is frequently used that denotes electrostatic interaction-[2], chemical interaction-[8] and steric hindrance-[9] induced mutual volume exclusion of macromolecules within a crowded and structureless medium
Data Source
Figure 1
Figure 1
Figure 2(A)~2(B)
AI summary
A composition for cell culture, the composition comprising glycosaminoglycan (GAG) having a molecular weight of from 60 to 2000 kDa, wherein the GAG has a molecular weight distribution comprising two or more peaks. Use of the composition for enhancing or influencing ECM deposition in a cell culture; or as a macromolecular crowding agent in cell culture. A cell culture medium comprising the composition. A method of eukaryote cell culture; a method of enhancing or influencing ECM deposition in eukaryote cell culture; and a method of manufacturing a cell culture medium.